These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36661303)

  • 1. A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence.
    Golding N; Price DJ; Ryan G; McVernon J; McCaw JM; Shearer FM
    Elife; 2023 Jan; 12():. PubMed ID: 36661303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2.
    Huisman JS; Scire J; Angst DC; Li J; Neher RA; Maathuis MH; Bonhoeffer S; Stadler T
    Elife; 2022 Aug; 11():. PubMed ID: 35938911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.
    Niu Y; Luo L; Yang S; Abudurusuli G; Wang X; Zhao Z; Rui J; Li Z; Deng B; Liu W; Zhang Z; Li K; Liu C; Li P; Huang J; Yang T; Wang Y; Chen T; Li Q
    Front Public Health; 2022; 10():949594. PubMed ID: 36187650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study.
    Tan J; Ge Y; Martinez L; Sun J; Li C; Westbrook A; Chen E; Pan J; Li Y; Cheng W; Ling F; Chen Z; Shen Y; Huang H
    Epidemiol Infect; 2022 Sep; 150():e171. PubMed ID: 36263615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological Characteristics and Transmissibility for SARS-CoV-2 of Population Level and Cluster Level in a Chinese City.
    Yu S; Cui S; Rui J; Zhao Z; Deng B; Liu C; Li K; Wang Y; Yang Z; Li Q; Chen T; Wang S
    Front Public Health; 2021; 9():799536. PubMed ID: 35118044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A statistical framework for tracking the time-varying superspreading potential of COVID-19 epidemic.
    Guo Z; Zhao S; Lee SS; Hung CT; Wong NS; Chow TY; Yam CHK; Wang MH; Wang J; Chong KC; Yeoh EK
    Epidemics; 2023 Mar; 42():100670. PubMed ID: 36709540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional national investigation of COVID-19 outbreaks in nurseries during rapid spread of the Alpha (B.1.1.7) variant of SARS-CoV-2 in England.
    Aiano F; McOwat K; Obi C; Powell AA; Flood J; Bhardwaj S; Stoker K; Haskins D; Wong B; Bertran M; Zavala M; Bosowski J; Jones SEI; Amin-Chowdhury Z; Coughlan L; Sinnathamby M; Zaidi A; Merrick R; Zhao H; Ismail S; Ramsay ME; Ladhani SN; Saliba V
    BMC Public Health; 2022 Oct; 22(1):1845. PubMed ID: 36183069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital contact tracing technologies in epidemics: a rapid review.
    Anglemyer A; Moore TH; Parker L; Chambers T; Grady A; Chiu K; Parry M; Wilczynska M; Flemyng E; Bero L
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013699. PubMed ID: 33502000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How time-scale differences in asymptomatic and symptomatic transmission shape SARS-CoV-2 outbreak dynamics.
    Harris JD; Park SW; Dushoff J; Weitz JS
    Epidemics; 2023 Mar; 42():100664. PubMed ID: 36706626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of viral infection outcomes in human seminal fluid from prior viral epidemics and Sars-CoV-2 may offer trends for viral sexual transmissibility and long-term reproductive health implications.
    Pike JFW; Polley EL; Pritchett DY; Lal A; Wynia BA; Roudebush WE; Chosed RJ
    Reprod Health; 2021 Jun; 18(1):123. PubMed ID: 34112171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral transmissibility of SARS-CoV-2 accelerates in the winter, similarly to influenza epidemics.
    Inaida S; Paul RE; Matsuno S
    Am J Infect Control; 2022 Sep; 50(9):1070-1076. PubMed ID: 35605752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analyses of superspreading of SARS-CoV-2 infections.
    Du Z; Wang C; Liu C; Bai Y; Pei S; Adam DC; Wang L; Wu P; Lau EHY; Cowling BJ
    Transbound Emerg Dis; 2022 Sep; 69(5):e3007-e3014. PubMed ID: 35799321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inferring the reproduction number using the renewal equation in heterogeneous epidemics.
    Green W; Ferguson N; Cori A
    J R Soc Interface; 2022 Mar; 19(188):20210429. PubMed ID: 35350879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending EpiEstim to estimate the transmission advantage of pathogen variants in real-time: SARS-CoV-2 as a case-study.
    Bhatia S; Wardle J; Nash RK; Nouvellet P; Cori A
    Epidemics; 2023 Sep; 44():100692. PubMed ID: 37399634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.